Kishor Mayekar

Array ( [id] => 3814840 [patent_doc_number] => 05789387 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Methods and compositions for treating fungal infections in mammals' [patent_app_type] => 1 [patent_app_number] => 8/697706 [patent_app_country] => US [patent_app_date] => 1996-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8079 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789387.pdf [firstpage_image] =>[orig_patent_app_number] => 697706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871629 [patent_doc_number] => 05763418 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => '3\'-substituted nucleoside derivatives' [patent_app_type] => 1 [patent_app_number] => 8/693161 [patent_app_country] => US [patent_app_date] => 1996-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28340 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763418.pdf [firstpage_image] =>[orig_patent_app_number] => 693161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876905 [patent_doc_number] => 05747474 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Immunosuppression by administration of N.sup.6,N.sup.6 -disubstituted cAMP\'s, analogues thereof, and related nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/688002 [patent_app_country] => US [patent_app_date] => 1996-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7599 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747474.pdf [firstpage_image] =>[orig_patent_app_number] => 688002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046784 [patent_doc_number] => 05912332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/690300 [patent_app_country] => US [patent_app_date] => 1996-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 5266 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912332.pdf [firstpage_image] =>[orig_patent_app_number] => 690300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4145200 [patent_doc_number] => 06031086 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Antisense oligonucleitide containing compositions and method of forming duplexes' [patent_app_type] => 1 [patent_app_number] => 8/693827 [patent_app_country] => US [patent_app_date] => 1996-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12631 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031086.pdf [firstpage_image] =>[orig_patent_app_number] => 693827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272555 [patent_doc_number] => 06323185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Anti-viral guanosine-rich oligonucleotides and method of treating HIV' [patent_app_type] => 1 [patent_app_number] => 8/682255 [patent_app_country] => US [patent_app_date] => 1996-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 107 [patent_no_of_words] => 58485 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323185.pdf [firstpage_image] =>[orig_patent_app_number] => 682255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3856821 [patent_doc_number] => 05705492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => '3\'-O-aminoacyl ARA uridines, method of making, and antiviral activity' [patent_app_type] => 1 [patent_app_number] => 8/677705 [patent_app_country] => US [patent_app_date] => 1996-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3872 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705492.pdf [firstpage_image] =>[orig_patent_app_number] => 677705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082146 [patent_doc_number] => 06054442 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Methods and compositions for modulation and inhibition of telomerase in vitro' [patent_app_type] => 1 [patent_app_number] => 8/675119 [patent_app_country] => US [patent_app_date] => 1996-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 21068 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054442.pdf [firstpage_image] =>[orig_patent_app_number] => 675119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834786 [patent_doc_number] => 05712377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Glycosides isolated from pollen, their sugar-free decomposition products and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/672651 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5911 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712377.pdf [firstpage_image] =>[orig_patent_app_number] => 672651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848337 [patent_doc_number] => 05719132 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil' [patent_app_type] => 1 [patent_app_number] => 8/671476 [patent_app_country] => US [patent_app_date] => 1996-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3010 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719132.pdf [firstpage_image] =>[orig_patent_app_number] => 671476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006892 [patent_doc_number] => 06005097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Processes for high-yield diastereoselective synthesis of dideoxynucleosides' [patent_app_type] => 1 [patent_app_number] => 8/663674 [patent_app_country] => US [patent_app_date] => 1996-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8190 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/005/06005097.pdf [firstpage_image] =>[orig_patent_app_number] => 663674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4054445 [patent_doc_number] => 05932718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Oligonucleotides having modified internucleoside linkages or terminal amino group' [patent_app_type] => 1 [patent_app_number] => 8/659924 [patent_app_country] => US [patent_app_date] => 1996-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6070 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932718.pdf [firstpage_image] =>[orig_patent_app_number] => 659924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047892 [patent_doc_number] => 05869466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Vitamin B.sub.12 mediated oral delivery systems for GCSF' [patent_app_type] => 1 [patent_app_number] => 8/651541 [patent_app_country] => US [patent_app_date] => 1996-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5521 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869466.pdf [firstpage_image] =>[orig_patent_app_number] => 651541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658619 [patent_doc_number] => 20030078416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'SUBSTITUTED PHENANTHROLINES' [patent_app_type] => new [patent_app_number] => 08/648270 [patent_app_country] => US [patent_app_date] => 1996-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7521 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078416.pdf [firstpage_image] =>[orig_patent_app_number] => 08648270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3735662 [patent_doc_number] => 05698535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'SIN-1A cyclodextrin inclusion complexes' [patent_app_type] => 1 [patent_app_number] => 8/571853 [patent_app_country] => US [patent_app_date] => 1996-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5254 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698535.pdf [firstpage_image] =>[orig_patent_app_number] => 571853 [rel_patent_id] =>[rel_patent_doc_number] =>)